Zerich Pharma Private Limited
About Zerich Pharma Private Limited
Data last updated:
Zerich Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 31 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2015PTC284692. Its GSTIN is 07AAACZ8721E1ZB (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Udai Kumar Verma and Rajesh Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shed No. 152 Type B Okhla Industrial Area Phase 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.6 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹34,867 (net margin 2%) and EBITDA of ₹47,046 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zerich Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No. 152 Type B Okhla Industrial Area Phase 1, New Delhi, Delhi, India – 110020
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Zerich Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zerich Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zerich Pharma Private Limited, buy the company report.
Financials of Zerich Pharma Private Limited
FY 2024 filings availableZerich Pharma Private Limited reported revenue of ₹17.6 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47,046 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,867 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zerich Pharma Private Limited, buy the company report.
Board of directors of Zerich Pharma Private Limited
Zerich Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Udai Kumar Verma | Director | 31 Aug 2015 | 11 Years 1 Months | Current |
| Rajesh Kumar Verma | Director | 15 Mar 2017 | 9 Years 7 Months | Current |
Auditor
Zerich Pharma Private Limited is audited by K B D G & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K B D G & CO | FY 2018 | 031595N |
Shareholding
The shareholding of Zerich Pharma Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zerich Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zerich Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zerich Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zerich Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACZ8721E1ZB | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zerich Pharma Private Limited, buy the company report.
Recent activity
Zerich Pharma Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Rajesh Kumar Verma ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Zerich Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 31 August 2015 (11+ years old) and is registered under CIN U24230DL2015PTC284692.
Zerich Pharma has 2 current directors:
- Udai Kumar Verma - Director
- Rajesh Kumar Verma - Director
The latest financial statements of Zerich Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Zerich Pharma is 07AAACZ8721E1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Zerich Pharma is U24230DL2015PTC284692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zerich Pharma was incorporated on 31 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Rajesh Kumar Verma ceased to be Additional Director on 30 Sep 2017. Sachin Kumar Verma ceased to be Additional Director on 30 Sep 2017. Rajesh Kumar Verma was appointed as Director on 15 Mar 2017. Zerich Pharma has 5 board changes on record in total.
The registered office of Zerich Pharma is at Shed No. 152 Type B Okhla Industrial Area Phase 1, New Delhi, Delhi, India – 110020.
Zerich Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Zerich Pharma is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.